BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 13760117)

  • 1. [Butanolamide of 1-methyl-D-lysergic acid and histamine liberation].
    LECOMTE J; LAPIERE CM
    C R Seances Soc Biol Fil; 1960; 154():2386-9. PubMed ID: 13760117
    [No Abstract]   [Full Text] [Related]  

  • 2. Antagonism between an antiserotonin-the butanolamide of 1-methyl-lysergic acid--and the effects of a histamine-liberating substance 48/80 B. W. in man.
    SICUTERI F; MICHELACCI S; FRANCHI G
    Int Arch Allergy Appl Immunol; 1959; 15():291-9. PubMed ID: 14446403
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical observations with 1-methyl-lysergic acid butanolamide (UML-491) in vascular headache.
    FRIEDMAN AP
    Angiology; 1960 Aug; 11():364-6. PubMed ID: 13825096
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental studies with the butanolamide and propanolamide of 1-methyl-lysergic acid.
    GELFAND MD; WEST GB
    Int Arch Allergy Appl Immunol; 1961; 18():286-91. PubMed ID: 13704268
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of UML-491 in the treatment of vascular headaches. An analysis of the effects of 1-methyl-D-lysergic acid (plus) butanolamide bimaleate (methysergide).
    FRIEDMAN AP; LOSIN S
    Arch Neurol; 1961 Mar; 4():241-5. PubMed ID: 13701987
    [No Abstract]   [Full Text] [Related]  

  • 6. Prophylactic and therapeutic properties of 1-methyl-lysergic acid butanolamide in migraine.
    SICUTERI F
    Int Arch Allergy Appl Immunol; 1959; 15():300-7. PubMed ID: 14446408
    [No Abstract]   [Full Text] [Related]  

  • 7. [First experiments in hemicrania and epilepsy with 1-methyl-lysergic acid butanolamide, a substance with antiserotonin effects].
    SICUTERI F
    Prog Med (Napoli); 1960 Jan; 16():20-2. PubMed ID: 14446409
    [No Abstract]   [Full Text] [Related]  

  • 8. Cross tolerance between D-2-brom-lysergic acid diethylamide (BOL-148) and the D-diethylamide of lysergic acid (LSD-25).
    ISBELL H; MINER EJ; LOGAN CR
    Psychopharmacologia; 1959 Nov; 1():109-16. PubMed ID: 14405871
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of a new compound, UML-491 (1-methyl-D-lysergic acid butanolamide), in the prevention of various types of headache.
    GRAHAM JR
    N Engl J Med; 1960 Dec; 263():1273-7. PubMed ID: 13707731
    [No Abstract]   [Full Text] [Related]  

  • 10. Blockade of 5-hydroxytryptamine antidiuresis in rats by 2-bromlysergic acid diethylamide tartrate and 1-methyl-lysergic acid butanolamide.
    CHODERA A
    J Pharm Pharmacol; 1963 Jun; 15():386-9. PubMed ID: 14020952
    [No Abstract]   [Full Text] [Related]  

  • 11. Some pharmacological actions of D-lysergic acid methyl carbinolamide.
    GLASSER A
    Nature; 1961 Jan; 189():313-4. PubMed ID: 13705953
    [No Abstract]   [Full Text] [Related]  

  • 12. Some vascular actions of 1-methyl-d-lysergic acid butanolamide with special reference to its reflex-blocking and antiserotonin actions.
    GEBBER GL; BECK L
    Med Bull (Ann Arbor); 1963; 29():182-94. PubMed ID: 13946952
    [No Abstract]   [Full Text] [Related]  

  • 13. THE PROPHYLACTIC EFFECT OF 1-METHYL-D-LYSERGIC ACID BUTANOLAMIDE (METHYSERGIDE) IN THE TREATMENT OF VASCULAR HEADACHE. A CLINICAL STUDY.
    CROWTHER DL
    Med Exp Int J Exp Med; 1964; 10():137-43. PubMed ID: 14129849
    [No Abstract]   [Full Text] [Related]  

  • 14. Actions of derivatives of lysergic acid on the heart of Venus mercenaria.
    WRIGHT AM; MOCRHEAD M; WELSH JH
    Br J Pharmacol Chemother; 1962 Apr; 18(2):440-50. PubMed ID: 14008412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxytocic effect of some d-lysergic acid cycloalkylamides.
    VOTAVA Z; PODVALOVA I; SEMONSKY M
    Nature; 1957 Mar; 179(4557):474-5. PubMed ID: 13407748
    [No Abstract]   [Full Text] [Related]  

  • 16. Lysergic acid diethylamide (LSD-25) antagonists. II. Development of tolerance in man to LSD-25 by prior administration of MLD-41 (1-methyl-d-lysergic acid diethylamide).
    ABRAMSON HA; SKLAROFSKY B; BARON MO; FREMONT-SMITH N
    AMA Arch Neurol Psychiatry; 1958 Feb; 79(2):201-7. PubMed ID: 13497364
    [No Abstract]   [Full Text] [Related]  

  • 17. [Chemical structure and lysergic acid derivative psychoses].
    SOLMS H
    Praxis; 1956 Aug; 45(32):746-9. PubMed ID: 13359249
    [No Abstract]   [Full Text] [Related]  

  • 18. A central nervous system effect of a nonhallucinatory lysergic acid derivative.
    SPIRTES MA; GUTH PS; POLLEY EH
    Experientia; 1958 Nov; 14(11):428. PubMed ID: 13609622
    [No Abstract]   [Full Text] [Related]  

  • 19. Production of a new lysergic acid derivative in submerged culture by a strain of Claviceps paspali Stevens & Hall.
    ARCAMONE F; CHAIN EB; FERRETTI A; MINGHETTI A; PENNELLA P; TONOLO A; VERO L
    Proc R Soc Lond B Biol Sci; 1961 Oct; 155():26-54. PubMed ID: 14036841
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of tryptophan and methyltryptophans on submerged lysergic acid fermentation by Claviceps paspali Stevens and Hall.
    ARCAMONE F; CHAIN EB; FERRETTI A; MINGHETTI A; PENNELLA P; TONOLO A
    Biochim Biophys Acta; 1962 Feb; 57():174-6. PubMed ID: 13862059
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.